Related references
Note: Only part of the references are listed.The many facets of macrophages in rheumatoid arthritis
Eleni Siouti et al.
BIOCHEMICAL PHARMACOLOGY (2019)
The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin
Christian D. Sadik et al.
SEMINARS IN IMMUNOLOGY (2018)
C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid
Lars Hornum et al.
PLOS ONE (2017)
A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA
Gaurav Mehta et al.
JOURNAL OF IMMUNOLOGY (2015)
Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
Stefan Siebert et al.
PHARMACOLOGICAL REVIEWS (2015)
Rapid-onset clinical and mechanistic effects of anti-C5aR treatment in the mouse collagen-induced arthritis model
C. Andersson et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Role of C3a Receptors, C5a Receptors, and Complement Protein C6 Deficiency in Collagen Antibody-Induced Arthritis in Mice
Nirmal K. Banda et al.
JOURNAL OF IMMUNOLOGY (2012)
Complement in the immunopathogenesis of rheumatic disease
Gunnar Sturfelt et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Complement Activation Triggers Metalloproteinases Release Inducing Cervical Remodeling and Preterm Birth in Mice
Juan M. Gonzalez et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis
Liyan Wang et al.
CLINICAL IMMUNOLOGY (2010)
A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis
Kutty Selva Nandakumar et al.
PLOS ONE (2010)
A novel bivalent single-chain variable fragment (scFV) inhibits the action of tumour necrosis factor α
Mengyuan Liu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2008)
New therapies for treatment of rheumatoid arthritis
Josef S. Smolen et al.
LANCET (2007)
Targeting TNF-α with a tetravalent mini-antibody TNF-TeAb
Mengyuan Liu et al.
BIOCHEMICAL JOURNAL (2007)
Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies
Hyun Lee et al.
NATURE BIOTECHNOLOGY (2006)
Interieukin-6: a new therapeutic target
Josef S. Smolen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor α
MY Liu et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2006)
Immunologic mechanisms in the pathogenesis of rheumatoid arthritis
GS Firestein
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2005)
Heterologous protein production using the Pichia pastoris expression system
S Macauley-Patrick et al.
YEAST (2005)
The N-terminal stem region of bovine and human β1,4-galactosyltransferase I increases the in vitro folding efficiency of their catalytic domain from inclusion bodies
EE Boeggeman et al.
PROTEIN EXPRESSION AND PURIFICATION (2003)
Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis
EP Grant et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.
EHS Choy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Recombinant protein expression in Pichia pastoris
JM Cregg et al.
MOLECULAR BIOTECHNOLOGY (2000)
Share Paper
